Vascarta
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4 Chatham Rd Ste 2, Summit, New Jersey, ...Phone Number
(201) 572-2484Website
www.vascarta.comRevenue
<$5 MillionIndustry
About Vascarta
Vascarta Org Chart
Is Vascarta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Vascarta has new funding data
Check out if Vascarta is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Vascarta recently announced quarterly report
Vascarta, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Vascarta
Click to see if Vascarta had a recent Job posting/layoffs
Check if Vascarta has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Vascarta launches new products
Recommended Actions
Reach out to Masked Content who joined Vascarta as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Vascarta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vascarta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vascarta.
Vascarta Tech Stack
A closer look at the technologies used by Vascarta
Vascarta News & Media
Vascarta Announces Addition of Richard Serbin to Leadership Team
Richard Serbin brings leadership in strategic planning and regulatory affairs. SUMMIT, N.J., June 9, 2026 /PRNewswire/ -- Vascarta Inc. is proud to announce the addition of Richard Serbin to its leadership team to serve in the role of Chief Strategy Officer. Richard Serbin will work...Vascarta Announces Positive Clinical Trial Results for Topical/Transdermal Curcumin Gel VAS-101 in Knee Osteoarthritis
Novel Transdermal Curcumin Formulation Demonstrates Pain Reduction and Improved Quality of Life in Phase 1b Clinical Trial Study published in Frontiers in Pain Research reports significant reduction in knee pain with topical curcumin formulation SUMMIT, N.J., April 1, 2026 /PRNewswire/ --...Novel Transdermal Curcumin (VAS-101) Improves Cardiac Mitochondrial Function in Sickle Cell Disease Mouse Model, New FDA Led Study Shows
SUMMIT, N.J., Dec. 3, 2025 /PRNewswire/ -- Vascarta Inc., is pleased to share results from a new study led by researchers at the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research (CBER), with scientists at the University of California, Irvine and Albert...Vascarta and CUNY Report Preclinical Breakthrough in Glioblastoma Treatment
SUMMIT, N.J., Nov. 10, 2025 /PRNewswire/ -- Vascarta Inc., a healthspan focused, clinical stage biopharmaceutical company advancing safe, patient friendly therapies for pain, inflammation, and, in collaboration with the City University of New York (CUNY), announce the publication of a...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vascarta
Vascarta is a clinical-stage pharmaceutical company, built on three core assets designed to increase therapeutic effectiveness while improving the patient experience. Our leading areas of study are in Sickle Cell disease, Osteoarthritis, Dementia, and Cancer. Vascarta: Moving Medicine Forward, Smartly.... Read More